CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to the corporate tax rate. H.R. 3937, Small Business Jobs Act of 2023 H.R. 3938, Build It in America Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
Pharmacy PHA
Issues related to drug pricing transparency, women's health, and COVID-19 testing, vaccination and treatment, including the Federal Retail Pharmacy Program. H.R. 1770, The Equitable Community Access to Pharmacist Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 H.R. 2679 - PBM Accountability Act of 2023 H.R. 3285 - To establish patient protections with respect to highly rebated drugs H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Insurance INS
Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 H.R. 2679 - PBM Accountability Act of 2023 H.R. 3285 - To establish patient protections with respect to highly rebated drugs H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| ROBERT TANNER WARBINTON | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. S. 113 - The Prescription Pricing for the People Act of 2023 S. 127 - The Pharmacy Benefit Manager Transparency Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Consumer Issues/Safety/Products CSP
Issues related to organized retail crime and consumer safety. S. 139 - The Organized Retail Crime Center Authorization Act of 2023 S. 140 - The Combatting Organized Retail Crime Act of 2023 H.R. 895 - The Combatting Organized Retail Crime Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| ROBERT TANNER WARBINTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.